By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Atorvastatin

Atorvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|607 words

What is Atorvastatin?

Atorvastatin is a prescription medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated cholesterol or other heart disease risk factors. Atorvastatin is one of the most commonly prescribed cholesterol-lowering medications worldwide.

Uses

Atorvastatin is approved for several cardiovascular conditions:

  • High cholesterol (hypercholesterolemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels in patients with primary hypercholesterolemia
  • Mixed dyslipidemia: Treats patients with elevated cholesterol and triglycerides while helping to raise HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Reduces heart attack and stroke risk in patients with multiple risk factors but no existing heart disease
  • Secondary prevention: Prevents additional cardiovascular events in patients with established coronary heart disease, stroke, or peripheral arterial disease
  • Familial hypercholesterolemia: Manages inherited conditions causing extremely high cholesterol levels, including homozygous and heterozygous familial hypercholesterolemia

How it works

Atorvastatin works by blocking HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing cells to absorb more cholesterol from the bloodstream. This dual action significantly lowers blood cholesterol levels and may also help stabilize existing arterial plaques, reducing the risk of heart attacks and strokes.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Muscle pain or weakness
  • Joint pain
  • Diarrhea
  • Nausea
  • Headache
  • Cold-like symptoms (runny nose, sore throat)
  • Indigestion
  • Insomnia

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain
  • Unexplained fatigue or weakness

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not take atorvastatin. Regular liver function monitoring may be required during treatment.
  • Pregnancy and breastfeeding: Atorvastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus or nursing infant.
  • Muscle disorders: Patients with a history of muscle disorders or those taking certain other medications may have increased risk of serious muscle problems including rhabdomyolysis.
  • Diabetes risk: Statin therapy may slightly increase blood sugar levels and the risk of developing type 2 diabetes, particularly in patients with pre-existing risk factors.
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require closer monitoring.

Interactions

Atorvastatin has several important drug interactions:

  • Cyclosporine: Significantly increases atorvastatin levels, raising the risk of muscle toxicity
  • Gemfibrozil and other fibrates: Increase risk of muscle problems when combined with statins
  • Warfarin: Atorvastatin may enhance anticoagulant effects, requiring closer INR monitoring
  • Digoxin: Atorvastatin can increase digoxin levels, potentially leading to toxicity
  • Certain antibiotics (clarithromycin, erythromycin): May increase atorvastatin concentrations
  • Antifungal medications (itraconazole, ketoconazole): Can significantly raise atorvastatin levels
  • Grapefruit juice: Large amounts may increase drug levels and side effect risk
  • Niacin (high doses): May increase risk of muscle-related side effects

Check interactions with the GMJ Interaction Checker

Dosage

Atorvastatin is typically taken once daily, with or without food. Standard dosing ranges from 10 mg to 80 mg daily, depending on the patient’s cholesterol levels, cardiovascular risk, and response to treatment. Most patients start with 10-20 mg daily, with dose adjustments made based on cholesterol level monitoring every 4-6 weeks. The maximum recommended dose is 80 mg daily. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific medical condition, other medications, and treatment goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Atorvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/atorvastatin-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Fluvastatin

By
GMJ News Desk
01/06/2026

Atorvastatin

By
GMJ News Desk
01/06/2026

Lovastatin

By
GMJ News Desk
01/06/2026

Rosuvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up